BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17202138)

  • 1. Transforming growth factor-beta-independent regulation of myogenesis by SnoN sumoylation.
    Wrighton KH; Liang M; Bryan B; Luo K; Liu M; Feng XH; Lin X
    J Biol Chem; 2007 Mar; 282(9):6517-24. PubMed ID: 17202138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumoylated SnoN represses transcription in a promoter-specific manner.
    Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
    J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
    Chanda A; Ikeuchi Y; Karve K; Sarkar A; Chandhoke AS; Deng L; Bonni A; Bonni S
    Cell Death Differ; 2021 Jan; 28(1):267-282. PubMed ID: 32770107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-β Responses.
    Liu S; Long J; Yuan B; Zheng M; Xiao M; Xu J; Lin X; Feng XH
    J Biol Chem; 2016 Nov; 291(47):24418-24430. PubMed ID: 27703003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
    Lee PS; Chang C; Liu D; Derynck R
    J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIF1γ protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1.
    Ikeuchi Y; Dadakhujaev S; Chandhoke AS; Huynh MA; Oldenborg A; Ikeuchi M; Deng L; Bennett EJ; Harper JW; Bonni A; Bonni S
    J Biol Chem; 2014 Sep; 289(36):25067-78. PubMed ID: 25059663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling.
    Nagano Y; Mavrakis KJ; Lee KL; Fujii T; Koinuma D; Sase H; Yuki K; Isogaya K; Saitoh M; Imamura T; Episkopou V; Miyazono K; Miyazawa K
    J Biol Chem; 2007 Jul; 282(28):20492-501. PubMed ID: 17510063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of TGFβ-induced epithelial-mesenchymal transition like phenotype by a PIAS1 regulated sumoylation pathway in NMuMG epithelial cells.
    Netherton SJ; Bonni S
    PLoS One; 2010 Nov; 5(11):e13971. PubMed ID: 21103059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Ubiquitylome Analysis Reveals the Specificity of RNF111/Arkadia E3 Ubiquitin Ligase for its Degradative Substrates SKI and SKIL/SnoN in TGF-β Signaling Pathway.
    Laigle V; Dingli F; Amhaz S; Perron T; Chouchène M; Colasse S; Petit I; Poullet P; Loew D; Prunier C; Levy L
    Mol Cell Proteomics; 2021; 20():100173. PubMed ID: 34740826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation.
    Erker Y; Neyret-Kahn H; Seeler JS; Dejean A; Atfi A; Levy L
    Mol Cell Biol; 2013 Jun; 33(11):2163-77. PubMed ID: 23530056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
    Zhu Q; Pearson-White S; Luo K
    Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ski and SnoN, potent negative regulators of TGF-beta signaling.
    Deheuninck J; Luo K
    Cell Res; 2009 Jan; 19(1):47-57. PubMed ID: 19114989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
    Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
    J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actin-cytoskeleton polymerization differentially controls the stability of Ski and SnoN co-repressors in normal but not in transformed hepatocytes.
    Caligaris C; Vázquez-Victorio G; Sosa-Garrocho M; Ríos-López DG; Marín-Hernández A; Macías-Silva M
    Biochim Biophys Acta; 2015 Sep; 1850(9):1832-41. PubMed ID: 26002202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
    Ihara M; Yamamoto H; Kikuchi A
    Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
    Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
    Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ski and SnoN: negative regulators of TGF-beta signaling.
    Luo K
    Curr Opin Genet Dev; 2004 Feb; 14(1):65-70. PubMed ID: 15108807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SnoN suppresses TGF-β-induced epithelial-mesenchymal transition and invasion of bladder cancer in a TIF1γ-dependent manner.
    Yin X; Xu C; Zheng X; Yuan H; Liu M; Qiu Y; Chen J
    Oncol Rep; 2016 Sep; 36(3):1535-41. PubMed ID: 27430247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.